G Medical Innovations Performance
| GMVDWDelisted Stock | USD 4.01 0.00 0.00% |
The firm retains a Market Volatility (i.e., Beta) of 1.99, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, G Medical will likely underperform. G Medical Innovations today retains a risk of 0.0%. Please check out G Medical variance, maximum drawdown, as well as the relationship between the Maximum Drawdown and skewness , to decide if G Medical will be following its current trending patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days G Medical Innovations has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable fundamental indicators, G Medical is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
| Begin Period Cash Flow | 6 M |
GMVDW |
G Medical Relative Risk vs. Return Landscape
If you would invest 401.00 in G Medical Innovations on August 31, 2024 and sell it today you would earn a total of 0.00 from holding G Medical Innovations or generate 0.0% return on investment over 90 days. G Medical Innovations is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded stocks are less volatile than GMVDW, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
G Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for G Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as G Medical Innovations, and traders can use it to determine the average amount a G Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| GMVDW |
Based on monthly moving average G Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of G Medical by adding G Medical to a well-diversified portfolio.
G Medical Fundamentals Growth
GMVDW Stock prices reflect investors' perceptions of the future prospects and financial health of G Medical, and G Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on GMVDW Stock performance.
| Return On Equity | -8.65 | |||
| Return On Asset | -1.26 | |||
| Operating Margin | (6.38) % | |||
| Revenue | 4.42 M | |||
| EBITDA | (37.75 M) | |||
| Cash And Equivalents | 278 K | |||
| Cash Per Share | 0.03 X | |||
| Total Debt | 2.09 M | |||
| Book Value Per Share | (0.44) X | |||
| Cash Flow From Operations | (18.48 M) | |||
| Total Asset | 4.83 M | |||
| Retained Earnings | (115.26 M) | |||
About G Medical Performance
Evaluating G Medical's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if G Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if G Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. G Medical Innovations Holdings Ltd was founded in 2014 and is based in Rehovot, Israel. G Medical is traded on NASDAQ Exchange in the United States.Things to note about G Medical Innovations performance evaluation
Checking the ongoing alerts about G Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for G Medical Innovations help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| G Medical is not yet fully synchronised with the market data | |
| G Medical has a very high chance of going through financial distress in the upcoming years | |
| G Medical Innovations has accumulated 2.09 M in total debt. G Medical Innovations has a current ratio of 0.39, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about G Medical's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the revenue of 4.42 M. Net Loss for the year was (25.07 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| G Medical Innovations has accumulated about 278 K in cash with (18.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03. |
- Analyzing G Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether G Medical's stock is overvalued or undervalued compared to its peers.
- Examining G Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating G Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of G Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of G Medical's stock. These opinions can provide insight into G Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in GMVDW Stock
If you are still planning to invest in G Medical Innovations check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the G Medical's history and understand the potential risks before investing.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |